Cleared Traditional

K223217 - Zynex Monitoring System

K223217 is an FDA 510(k) clearance for Zynex Monitoring System, manufactured by Zynex Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DSB cleared through the Traditional 510(k) pathway after a 242-day FDA review.

K223217 · Zynex Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
242d
Days
Class 2
Risk

K223217 is an FDA 510(k) clearance for the Zynex Monitoring System, Model CM-1600. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Zynex Medical, Inc. (Englewood, US). The FDA issued a Cleared decision on June 16, 2023 after a review of 242 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Zynex Medical, Inc. devices

FDA 510(k) Submission Details - K223217

510(k) Number K223217 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 17, 2022
Decision Date June 16, 2023
Days to Decision 242 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 125d · This submission: 242d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSB Device Classification - Class 2, Special Controls

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 17
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K223217.
Re:Balans
K243727 · Mode Sensors AS · Oct 2025
Edema Guard Monitor (EGM) CardioSet-001
K250922 · Cardioset Medical , Ltd. · Sep 2025
SOZO Pro
K232089 · ImpediMed Limited · Oct 2023
Bodyport Cardiac Scale
K211585 · Bodyport, Inc. · Jul 2022
SOZO
K203473 · ImpediMed Limited · Apr 2021
SOZO Body Fluid Analyzer
K193410 · ImpediMed Limited · Oct 2020